BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3349462)

  • 21. Interaction of estramustine with tubulin isotypes.
    Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
    Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro.
    Mareel MM; Storme GA; De Bruyne GK; Van Cauwenberge RM
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):199-210. PubMed ID: 7201395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of microtubule inhibitors on malignant invasion in vitro.
    Mareel MM; De Brabander MJ
    J Natl Cancer Inst; 1978 Sep; 61(3):787-92. PubMed ID: 278855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of estramustine on microtubuli is different from the direct action via oxygen radicals on DNA and cell membrane.
    Henriksson R; Bjermer L; Von Schoultz E; Grankvist K
    Anticancer Res; 1990; 10(2A):303-9. PubMed ID: 2346305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study on the effects of estradiol and estramustine on gastrointestinal cell lines.
    Harrison JD; Watson S; Ellis IO; Morris DL
    Eur J Surg Oncol; 1990 Apr; 16(2):116-20. PubMed ID: 2182340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
    Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
    Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.
    Stearns ME; Wang M; Tew KD; Binder LI
    J Cell Biol; 1988 Dec; 107(6 Pt 2):2647-56. PubMed ID: 3060470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular effects of estramustine (Estracyt/Emcyt).
    Tew KD; Stearns ME
    Prog Clin Biol Res; 1989; 303():169-75. PubMed ID: 2674983
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of microtubule inhibitors-taxol, vinblastine and estramustine on the growth and p53 gene expression in the hormone independent human prostatic JCA-1 cells.
    Darby E; An S; Ng C; Hsieh TC; Mallouh C; Wu JM
    Anticancer Res; 1996; 16(6B):3647-52. PubMed ID: 9042236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estramustine-based chemotherapy.
    Hudes G
    Semin Urol Oncol; 1997 Feb; 15(1):13-9. PubMed ID: 9050135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S; McCauley RA; Dexter DW; Hudes GR
    Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estramustine: a novel radiation enhancer in human carcinoma cells.
    Ryu S; Gabel M; Khil MS; Lee YJ; Kim SH; Kim JH
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):99-104. PubMed ID: 7916009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism based chemotherapy for prostate cancer.
    Sheridan VR; Tew KD
    Cancer Surv; 1991; 11():239-54. PubMed ID: 1841754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
    Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.
    Arah IN; Dixon SC; Horti J; Figg WD
    Neoplasma; 1999; 46(2):117-23. PubMed ID: 10466436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of vinblastine and estramustine to isolated plasma membrane fractions from human prostate and prostatic tumors.
    Batra S; Larsson I
    Cancer Lett; 1996 Sep; 106(2):217-20. PubMed ID: 8844975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
    Høisaeter PA
    Scand J Urol Nephrol Suppl; 1977; (46):1-72. PubMed ID: 279091
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
    Tew KD; Erickson LC; White G; Wang AL; Schein PS; Hartley-Asp B
    Mol Pharmacol; 1983 Sep; 24(2):324-8. PubMed ID: 6888373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural organic compounds that affect to microtubule functions.
    Iwasaki S
    Yakugaku Zasshi; 1998 Apr; 118(4):112-26. PubMed ID: 9564789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.